Zobrazeno 1 - 10 of 10 pro vyhledávání: '"Petra Büchner-Steudel"'
1
Akademický článek
Prediction of resistance to bevacizumab plus FOLFOX in metastatic colorectal cancer-Results of the prospective multicenter PERMAD trial.
Autor: Thomas Seufferlein, Ludwig Lausser, Alexander Stein, Dirk Arnold, Gerald Prager, Stefan Kasper-Virchow, Michael Niedermeier, Lothar Müller, Stefan Kubicka, Alexander König, Petra Büchner-Steudel, Kai Wille, Andreas W Berger, Angelika M R Kestler, Johann M Kraus, Silke D Werle, Lukas Perkhofer, Thomas J Ettrich, Hans A Kestler
Publikováno v: PLoS ONE, Vol 19, Iss 6, p e0304324 (2024)
BackgroundAnti-vascular endothelial growth factor (VEGF) monoclonal antibodies (mAbs) are widely used for tumor treatment, including metastatic colorectal cancer (mCRC). So far, there are no biomarkers that reliably predict resistance to anti-VEGF mA
Externí odkaz: https://doaj.org/article/70304decadfc447c8eecb19ea70285b5
Zobrazit plný text záznamu
2
Quality of life and outcome of patients with metastatic pancreatic cancer receiving first‐line chemotherapy with nab‐paclitaxel and gemcitabine: Real‐life results from the prospective QOLIXANE trial of the Platform for Outcome, Quality of Life and Translational Research on Pancreatic Cancer registry
Autor: Jens Papke, Holger Schulz, Alexander Reichart, Jürgen Wehmeyer, Eike Gallmeier, Petra Büchner-Steudel, Martin Wolf, Lutz Jacobasch, Jan Wierecky, Klaus-Ulrich Däßler, Mark-Oliver Zahn, Salah-Eddin Al-Batran, Hans-Detlev Harich, Jörg Weniger, Lars Hahn, U. R. Peters, Dirk Behringer, Daniel Pink, Hans-Peter Feustel, Heinz-Gert Höffkes, Thomas Fietz, Marina Schaaf, Matthias Groschek, Claudia Pauligk, Arndt Vogel, Oliver Waidmann, Jens Uhlig, Steffen Dörfel, Ursula Vehling-Kaiser, G. Schuch, Wolfgang Blau, Helmut Forstbauer, Ludwig Fischer von Weikersthal, Martina Stauch, Arbeitsgemeinschaft Internistische Onkologie, Stephan Bildat, Jörg Schubert, Stefan Mahlmann, Michael Koenigsmann, Rudolf Schlag, Henning Eschenburg, Jörg Trojan, Albrecht Kretzschmar, Volker Kunzmann, Uwe Schwindel, Caroline Schönherr, Karin Waibel, Nils Homann, Ali Aldaoud, Thorsten Oliver Götze, Gerrit zur Hausen, Gabriele Margareta Siegler, Christoph Springfeld, Ralf-Dieter Hofheinz, Helmut Messmann, Marcus-A Wörns, Thomas J. Ettrich
Publikováno v: International Journal of Cancer. 148:1478-1488
Few data exist on health-related quality of life (QoL) in patients with metastatic pancreatic cancer (mPC) receiving first-line chemotherapy (Awad L ZE, Mesbah M Boston, MA. Applying survival data methodology to analyze quality of life data, in Mesba
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7f49ed33d11961538a1152d28c1944a2
https://doi.org/10.1002/ijc.33336
Zobrazit plný text záznamu
3
Nintedanib plusmFOLFOX6as second‐line treatment of metastatic, chemorefractory colorectal cancer: The randomised, placebo‐controlled, phaseII TRICC‐Cstudy (AIO‐KRK‐0111)
Autor: Carla Verena Hannig, Thomas R. W. Herrmann, Lukas Perkhofer, Thomas J. Ettrich, Thomas Seufferlein, Petra Büchner-Steudel, Andreas Berger, Patrick C. Hermann, Holger Hebart, Thomas J. Hoffmann, Thomas Decker, Volker Heinemann, M Güthle, Ralf-Dieter Hofheinz
Publikováno v: International Journal of Cancer. 148:1428-1437
Nintedanib is a triple angiokinase inhibitor of vascular endothelial growth factor receptor 1-3, fibroblast growth factor receptor 1-3 and platelet-derived growth factor receptor-a/-b. Thereby, it targets angiogenic escape mechanisms. The trial TyRos
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb995a5ed7214e893b0dc47e6fe95a1f
https://doi.org/10.1002/ijc.33296
Zobrazit plný text záznamu
4
Efficacy and Safety of CAP7.1 as Second-Line Treatment for Advanced Biliary Tract Cancers: Data from a Randomised Phase II Study
Autor: Johannes Meiler, Victor Rodriguez-Laval, Steffen Heeg, Anja A. Kühl, Ruza Arsenic, Ulrich-Frank Pape, Karel Caca, Stefan Kasper, Holger Jansen, Arndt Vogel, Oswald Burkhard, Petra Büchner-Steudel, Marianne Sinn, Peter Treasure, Nalân Utku, Lothar Müller
Publikováno v: Cancers
Volume 12
Issue 11
Cancers, Vol 12, Iss 3149, p 3149 (2020)
CAP7.1 is a novel topoisomerase II inhibitor, converted to active etoposide via carboxylesterase 2 (CES2), with signals of efficacy in treatment-refractory solid tumours. In a Phase II trial, 27 patients with advanced biliary tract cancers (BTC) were
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0afa236a2b6ccc2afac733832775c664
Zobrazit plný text záznamu
5
Quality of life and outcome of patients with metastatic pancreatic cancer receiving first-line chemotherapy with nab-paclitaxel and gemcitabine: Real-life results from the prospective QOLIXANE trial of the Platform for Outcome, Quality of Life and Translational Research on Pancreatic Cancer registry
Autor: Salah-Eddin, Al-Batran, Ralf-Dieter, Hofheinz, Alexander, Reichart, Claudia, Pauligk, Caroline, Schönherr, Rudolf, Schlag, Gabriele, Siegler, Steffen, Dörfel, Michael, Koenigsmann, Mark-Oliver, Zahn, Jörg, Schubert, Ali, Aldaoud, Heinz-Gert, Höffkes, Holger, Schulz, Lars, Hahn, Jens, Uhlig, Wolfgang, Blau, Martina, Stauch, Jörg, Weniger, Martin, Wolf, Lutz, Jacobasch, Stephan, Bildat, Jürgen, Wehmeyer, Nils, Homann, Jörg, Trojan, Oliver, Waidmann, Thomas, Fietz, Hans-Peter, Feustel, Matthias, Groschek, Jan, Wierecky, Karin, Waibel, Stefan, Mahlmann, Uwe, Schwindel, Uwe, Peters, Gunter, Schuch, Daniel, Pink, Henning, Eschenburg, Marcus-A, Wörns, Hans-Detlev, Harich, Ludwig Fischer, von Weikersthal, Klaus-Ulrich, Däßler, Dirk M, Behringer, Helmut, Messmann, Albrecht, Kretzschmar, Eike, Gallmeier, Helmut, Forstbauer, Volker, Kunzmann, Jens, Papke, Petra, Büchner-Steudel, Ursula, Vehling-Kaiser, Christoph, Springfeld, Arndt, Vogel, Thomas J, Ettrich, Marina, Schaaf, Gerrit Zur, Hausen, Thorsten Oliver, Götze
Publikováno v: International journal of cancerREFERENCES. 148(6)
Few data exist on health-related quality of life (QoL) in patients with metastatic pancreatic cancer (mPC) receiving first-line chemotherapy (Awad L ZE, Mesbah M Boston, MA. Applying survival data methodology to analyze quality of life data, in Mesba
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::b5ba8201916c628cf641bb473a0c2c39
https://pubmed.ncbi.nlm.nih.gov/33038277
Zobrazit plný text záznamu
8
Multicenter phase I/II feasibility study of adjuvant treatment with S-1 in patients after R0-resection of adenocarcinoma of the stomach and esophagogastric junction (GMBH-STO-0114)
Autor: Volker Heinemann, Lutz P. Müller, C Schulz, Thomas J. Ettrich, Petra Büchner-Steudel, Kathrin Heinrich, Sebastian Stintzing
Publikováno v: Annals of Oncology. 30:v303
Background S-1 has been shown to be an effective adjuvant treatment for East Asian patients who underwent gastrectomy with a D2 lymph-node dissection for stage II/III gastric cancer. We designed a phase I/II study to evaluate the efficacy, toxicity a
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d07b3d6c2dd1afa4a0dc097c0dc4584a
https://doi.org/10.1093/annonc/mdz247.113
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje